Company Encyclopedia
View More
name
Bone Biologics
BBLG.US
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company’s lead medical device NELL-1/DBM, an osteopromotive recombinant protein that provides target-specific control over bone regeneration. It also develops NELL-1/DBM fusion device used in lumbar spinal fusion. The company’s NELL-1 platform technology used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.
1.935 T
BBLG.USMarket value -Rank by Market Cap -/-

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    FDA Qualifies Total Hip Bone Mineral Density As Surrogate Endpoint For Osteoporosis Drug Development

    FDA: QUALIFIES TOTAL HIP BONE MINERAL DENSITY (BMD) AS SURROGATE ENDPOINT FOR OSTEOPOROSIS DRUG DEVELOPMENT

    Reuters·
    US
    BBLG
    +2.19%
    Reuters·
    US
    BBLG
    +2.19%

    Cerapedics reveals 24-month ASPIRE Study results in Spine journal, showing PearlMatrix™ P-15 Peptide Bone Graft outperformed autograft with superior clinical success and time-to-fusion, with over double the patients involved.

    Results from the pivotal IDE study ASPIRE revealed that PearlMatrix achieved greater clinical success and faster time-to-fusion at 24 months compared to local autograft. The study, known for its rigorous design, included over twice the number of patients. This demonstrates the superiority of PearlMatrix in terms of both clinical outcomes and efficiency in achieving fusion within the specified timeframe.

    Unusual Whales·
    US
    BBLG
    +2.19%
    Unusual Whales·
    US
    BBLG
    +2.19%

    10:16 ET AI-Based Analysis of CT Scans Taken for Many Reasons May Also Reveal Weakened Bones

    A study by NYU Langone Health reveals that AI can analyze CT scans originally taken for other medical issues to detect signs of osteoporosis. The AI tool, developed with Visage, will enable opportunistic screening for low bone density in hospitals. The research analyzed over 538,000 CT scans and found trends in bone loss across diverse populations. The study highlights the potential of repurposing existing medical images to identify osteoporosis, which affects millions of Americans, particularly women over 50. The findings suggest that AI could significantly improve osteoporosis diagnosis and management.

    prnewswire·
    US
    BBLG
    +2.19%
    prnewswire·
    US
    BBLG
    +2.19%

    Osteoporosis kills more men than prostate cancer, yet often goes undiagnosed

    Osteoporosis is commonly seen as a women's disease, but men face even deadlier consequences from bone fractures.

    MSN·
    US
    BBLG
    +2.19%
    MSN·
    US
    BBLG
    +2.19%

    InventHelp inventor creates Bone Spur Relief supplement to reduce pain & heal - aimed at increasing skeletal strength.

    In Pittsburgh on October 28, 2025, an inventor from Montgomery, Illinois shared their motivation for creating a new product. The inventor expressed their aim to decrease pain and enhance the healing process of bone spurs with their invention, the BONE SPUR RELIEF. The formula they developed is designed to boost skeletal strength, leading to a reduction in discomfort and a more efficient recovery for individuals with bone spurs.

    Unusual Whales·
    US
    BBLG
    +2.19%
    Unusual Whales·
    US
    BBLG
    +2.19%
    © 2025 Longbridge｜Disclaimer